ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q4Scopus Q4SCImago #23,910Hybrid

Astim Allerji Immunoloji

Identifier (ISSN):1308-9234(Print)
•
Publisher:Bilimsel Tip Yayinevi
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
0.4– 0
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Astim Allerji Immunoloji

WoS Q4
00110.220230.320240.420250.42026
Annual Impact Factor Metric
Current (2026):0.4
Scopus SJR & RankScopus Q4
0.17
#23,910

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
6

6 papers with at least that number of citations each

WoS: ESCIQ4
Self-Citation RateN/A
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
28articles/year
79.37% Gold OA•93.75% Original Research

Aims & Scope

Asthma Allergy Immunology has been published three times a year in April, August and December as the official and periodical journal of the Turkish National Society of Allergy and Clinical Immunology since 2003. All articles published in the journal have been available online since 2003. A peer reviewed system is used in evaluation of the manuscripts submitted to Asthma Allergy Immunology. The official language of the journal is English. The aim of the journal is to present advances in the field of allergic diseases and clinical immunology to the readers. In accordance with this goal, manuscripts in the format of original research, review, case report, articles about clinical and practical applications and editorials, short report and letters to the editor about allergic diseases and clinical immunology are published in the journal. The target reader population of the Asthma Allergy Immunology includes specialists and residents of allergy and clinical immunology, pulmonology, internal medicine, pediatrics, dermatology and otolaryngology as well as physicians working in other fields of medicine interested in allergy and immunological diseases.

Topics Covered (Recognized by AI)
MedicineBiologyImmunologyInternal MedicinePathologyGeneticsAllergyPsychologyChemistryPathology & Diseases
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

ALLERGY

Q4
Rank35/40
IndexESCI
JCIESCI2026

ALLERGY

Q4
Rank34/40
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

11 year
2026Latest
IF0.4
Articles / Year16
Total Citations1
2025
IF0.4
Articles / Year49
Total Citations13
2024
IF0.3
Articles / Year49
Total Citations40
2023
IF0.2
Articles / Year40
Total Citations68
2022
IF—
Articles / Year22
Total Citations43

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #23,910Scopus Q4SCImago Profile
Scopus Coverage:2014-2016, 2019-2025
Scopus Broad Areas:Immunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q4
0.17

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q4
Citations / Doc (2 years)
0.52

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,346 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations61
3-Year Documents123
Citable Documents107

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate62.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

ImmunologyQ4
Immunology and AllergyQ4
Pulmonary and Respiratory MedicineQ4
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ALLERGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Astim Allerji Immunoloji (ISSN: 1308-9234) is a peer-reviewed international scholarly journal in the field of ALLERGY, published by Bilimsel Tip Yayinevi in Turkey. The periodical holds a Journal Impact Factor (JIF) of 0.40, ranking in quartile Q4 of Web of Science (ESCI), a Scopus SJR indicator of 0.170 (Q4), an H-index of 6.

The journal enforces rigorous peer evaluation with an annual output of approximately 28 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,346 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Bilimsel Tip Yayinevi
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 4bed7efd-c7d4-47be-a5ba-91994e80c81f
Database Updated: 2026-09-28